Diseases such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease affect millions of people around the world.
These conditions slowly damage the brain over many years, causing nerve cells to die.
As more of these cells are lost, people may develop memory problems, confusion, personality changes, difficulty moving, and trouble performing everyday tasks. For many families, these illnesses eventually require full-time care and support.
Although scientists have made progress in developing treatments, there is still no cure for most neurodegenerative diseases.
Some newer Alzheimer’s drugs can slow the disease in certain patients, especially during the early stages, but they cannot rebuild damaged brain tissue or restore neurons that have already been lost. This limitation has led researchers to search for entirely new approaches that could help the brain repair itself.
A team of scientists from Shibaura Institute of Technology in Japan may have found an intriguing possibility. Their study, published online in ACS Chemical Neuroscience on July 3, 2025, explored whether specially modified forms of vitamin K could encourage the growth of new neurons. The research was led by Associate Professor Yoshihisa Hirota and Professor Yoshitomo Suhara.
Most people know vitamin K because it helps blood clot properly and supports healthy bones. In recent years, however, researchers have discovered that vitamin K may also play an important role in brain health. Previous studies suggested that one natural form of vitamin K, called menaquinone-4 or MK-4, can help immature brain cells develop into neurons.
Neurons are the communication cells of the nervous system. They send signals throughout the brain and body, allowing people to think, remember, move, and perform countless other functions. Because neurodegenerative diseases destroy these cells, finding ways to replace them has become a major goal of medical research.
The Japanese research team wanted to see whether they could make vitamin K more powerful. They created 12 new vitamin K-related compounds by combining vitamin K with other chemical structures known to influence brain development. Some of these compounds included elements related to vitamin A, which is already known to support the growth and development of nerve cells.
The scientists tested these new compounds in mouse neural progenitor cells. These are immature cells that have the ability to develop into different types of brain cells. The results were encouraging. One newly designed compound was about three times more effective than natural vitamin K at encouraging these cells to become neurons.
The researchers then investigated why the compound worked so well. Their experiments pointed to a brain signaling pathway involving a receptor called mGluR1.
This receptor helps neurons communicate with each other and plays an important role in normal brain function. Problems involving mGluR1 have previously been linked to movement difficulties and other neurological symptoms.
Further testing showed that the new vitamin K compound attached more strongly to this receptor than natural vitamin K. The compound also entered cells efficiently and was converted into active forms that could influence brain function.
Perhaps the most exciting finding came from animal experiments. The researchers discovered that the compound was able to cross the blood-brain barrier.
This protective barrier prevents many substances from entering the brain. Successfully crossing it is a major challenge for drug development. Once inside the brain, the new compound produced higher levels of active vitamin K than naturally occurring forms.
These findings suggest that vitamin K-based compounds could someday become part of treatments designed to help replace lost neurons. Instead of simply reducing symptoms, future therapies might encourage the brain to generate new nerve cells and potentially restore some lost function.
However, it is important to keep the findings in perspective. This research was conducted in laboratory cells and mice. The treatment has not been tested in people, and there is no evidence yet that it can reverse Alzheimer’s disease, Parkinson’s disease, or other neurological conditions in humans.
Even so, the study opens an exciting new direction for research. Scientists now have a better understanding of how vitamin K may influence brain cell development and which biological pathways may be involved.
Future studies will determine whether these discoveries can eventually be translated into safe and effective treatments.
